Here are four things to know.
1. Pfizer’s consumer health business, which has been for sale for months, includes products such as Advil, Chapstick and Centrum vitamins.
2. P&G is offering around $15 billion for the consumer health business, while Pfizer is seeking at least $20 billion, sources familiar with the discussions told CNBC.
3. Johnson & Johnson, GlaxoSmithKline and Reckitt Benckiser Group already looked at purchasing Pfizer’s consumer health business.
4. Pfizer is also considering other options for the business, including a joint venture with other pharmaceutical companies. The drugmaker hopes to reach a decision on the consumer health business by May.
More articles on supply chain:
Study: 40% of providers have canceled surgeries over supply shortages
10 immensely overinflated hospital costs
Beating Amazon to the punch: Zipline launches drone to deliver medical supplies at 79 mph
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
